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Abstract
Background: Malaria has recently been identified as a candidate for global eradication. This process will
take the form of a series of national eliminations. Key issues must be considered specifically for elimination
strategy when compared to the control of disease. Namely the spread of drug resistance, data scarcity and
the adverse effects of failed elimination attempts. Mathematical models of various levels of complexity have
been produced to consider the control and elimination of malaria infection. If available, detailed data on
malaria transmission (such as the vector life cycle and behaviour, human population behaviour, the
acquisition and decay of immunity, heterogeneities in transmission intensity, age profiles of clinical and
subclinical infection) can be used to populate complex transmission models that can then be used to design
control strategy. However, in many malaria countries reliable data are not available and policy must be
formed based on information like an estimate of the average parasite prevalence.
Methods: A simple deterministic model, that requires data in the form of a single estimate of parasite
prevalence as an input, is developed for the purpose of comparison with other more complex models. The
model is designed to include key aspects of malaria transmission and integrated control.
Results: The simple model is shown to have similar short-term dynamic behaviour to three complex
models. The model is used to demonstrate the potential of alternative methods of delivery of controls.
The adverse effects on clinical infection and spread of resistance are predicted for failed elimination
attempts. Since elimination strategies present an increased risk of the spread of drug resistance, the model
is used to demonstrate the population level protective effect of multiple controls against this very serious
threat.
Conclusion: A simple model structure for the elimination of malaria is suitable for situations where data
are sparse yet strategy design requirements are urgent with the caveat that more complex models,
populated with new data, would provide more information, especially in the long-term.
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Background
Since the failed campaign to eradicate malaria in the mid-
dle of the last century [1], control of malaria infection has
been targeted at reduction in morbidity and mortality
while protecting the longevity of chemotherapy from drug
resistance. Anti-malarial drug resistance occurs when
spontaneously arising mutants with reduced drug suscep-
tibility are provided with a survival advantage by the use
of the anti-malarial. The sparing use of new anti-malarial
drugs has been recommended to minimize the selective
pressure on the parasite [2,3]. This is a reasonable argu-
ment if the aim is to accept the continued presence of
malaria and control its most deleterious effects. However,
recent initiatives stating elimination and eventually erad-
ication as the new aim of malaria control require a sea
change in strategy [4]. Strategies designed to extend the
lifespan of chemotherapies conflict with those likely to be
required to successfully and rapidly eliminate the disease
[5]. Elimination strategies require that transmission rather
than disease is targeted. In this situation, where data are
often sparse [6] and the cumulative effect of multiple con-
trol methods is complex and dependent on transmission
intensity and many other factors, mathematical model-
ling plays an important role in informing decisions [7].
The phases of eradication of an infectious disease as
defined by Molyneux et al [8], are as follows:
￿ Control: Reduction of disease incidence, prevalence,
morbidity or mortality to a locally acceptable level as
a result of deliberate efforts. Continued intervention
measures are required to maintain the reduction.
￿ Elimination of disease: Reduction to zero of the inci-
dence of a specified disease in a defined geographical
area as a result of deliberate efforts. Continued inter-
vention measures are required.
￿ Elimination of infection: Reduction to zero of the
incidence of infection caused by a specified agent in a
defined geographical area as a result of deliberate
efforts. Continued measures to prevent re-establish-
ment of transmission are required.
￿ Eradication: Permanent reduction to zero of the
worldwide incidence of infection caused by a specific
agent as a result of deliberate efforts. Intervention
measures are no longer needed.
￿ Extinction: The specific infectious agent no longer
exists in nature or the laboratory
A simple mathematical structure is used to consider the
'elimination of infection' phase. The potential of combin-
ing multiple strategies that applied singly would not nec-
essarily result in elimination, but applied in combination
have the potential to achieve this aim within the timelines
predicted by other more complex modelling exercises [9]
is demonstrated. It is predicted that non-treatment con-
trol measures (such as deployment of an effective vaccine
or insecticide-treated bed nets (ITNs)) could prevent the
spread of drug resistance (as suggested in [3]) in a similar
way to drug combination therapy, but at the population
rather than individual level (as with multiple first-line
therapies [10]). It is predicted that in many scenarios even
a failure to eliminate the disease would result in a lower
cumulative morbidity and mortality than if the attempt
were never made. The key exception to this result is the
scenario where drug resistance is spreading. Then if the
same drugs are used in an elimination strategy, an acceler-
ation of the spread of resistance is predicted, in some cases
resulting in higher morbidity following failed elimination
attempts.
Eradication of any disease is an ambitious aim that to date
has only been achieved for smallpox. There are only a few
WHO sanctioned disease targets for eradication or elimi-
nation and malaria is not listed among them. Therefore,
considering the potential outcomes of failures to elimi-
nate is an important role for mathematical modelling.
Methods
Baseline model
This simple compartmental model is based on a previ-
ously fully parameterized model for malaria transmission
[11] with four compartments with parameters estimated
from data sets from areas of diverse transmission intensi-
ties ranging from hypo to holoendemic transmission [11].
The model represents a situation where disease is being
controlled using treatment of symptomatic malaria and
where there may or may not be some reduction of trans-
mission by other means. The model is suitable for all
transmission intensities since it includes a clinically
immune state that can be maintained through boosting or
lost in the absence of exposure. The model outputs
include parasite prevalence (as used in [9]) and clinical
infection.
Elimination model
The baseline model is augmented with three examples
from the arsenal of interventions targeting malaria trans-
mission that are either currently available or in the final
stages of development:
￿ ITNs and other vector control methods, resulting in a
reduction in the force of infection by 30% [12]
￿ Artemisinin combination therapy.Malaria Journal 2009, 8:212 http://www.malariajournal.com/content/8/1/212
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❍ Annual mass screen and treat (MSAT) policy reach-
ing a coverage of 80% of the infected population
within three months of each year [5] assuming that the
drug will effectively clear blood stage parasites in an
average of two weeks' time
￿ Vaccination using the RTS, S vaccine [13], assuming a
vaccine induced reduction in the force of infection by
50% [14] and a duration of immunity of between 1 and
10 years.
❍ Given annually to all age groups, reaching a cover-
age of 80% within a three-month period. The method
of administration could be similar to or in conjunc-
tion with a MSAT programme.
One plausible intervention that may be widely used in the
future is also considered:
￿ Deployment of the transmission blocking drugs (specif-
ically the gametocidal action of) primaquine or tafeno-
quine [15].
❍ given in combination with every treatment for the
duration of the treated infection
❍ given annually reaching a coverage of 80% with a
duration of effect of two weeks
Full details of both models can be found in Additional file
1.
Elimination is modelled as beginning from a starting sce-
nario, where transmission is being maintained at a fixed
level using malaria control and resistance to drug therapy
is at a negligible level. To measure the impact of an elim-
ination strategy, the predicted cumulative episodes of
clinical malaria are recorded over a 20-year period from
the start of the elimination strategy, and are compared
with the number of episodes that would arise with a con-
tinuation of the control situation. The cumulative propor-
tion of infections that are treated is also recorded as a
measure of cumulative selective pressure. The predicted
impact of an elimination strategy is the percentage differ-
ence between the cumulative episodes of clinical malaria
(cumulative person-years of clinical infection averted) or
drug pressure, given continued control and given an elim-
ination attempt. Thus positive values of these differences
represent a positive impact and negative values represent
deleterious effects of elimination strategies.
It is assumed that the potential for the spread of anti-
malarial drug resistance is dependent on the selective
pressure from treatment and the proportion of infections
that are already resistant, which in turn increases with the
percentage of resistant infections resulting in an increas-
ing average duration of infection under treatment at the
population level. Increasing the average duration of infec-
tion would lead to increased transmission, which in turn
could lead to more drug treatments and further spread of
resistance unless transmission is sufficiently reduced. If
transmission is not sufficiently reduced, the process of
selective pressure begetting longer durations of infection
would eventually render the treatment useless with the
population average duration of an infection under treat-
ment approaching that of an untreated infection.
The model assumptions are conservative for drug action
by assuming no prophylactic effect of the drug post recov-
ery (see equation for η (t) in Additional File 1). This is a
reasonable assumption for artemisinin or quinine mono-
therapies because of the rapid elimination kinetics of the
drug, and is also reasonable for artemisinin combination
therapy (ACT) in low transmission settings since individ-
uals are unlikely to be exposed to malaria infection during
the period of "post-treatment prophylaxis" of the partner
drug. However, this prophylactic effect could be signifi-
cant in high transmission areas and act to increase the
speed of elimination and also the spread of resistance. It
is assumed that during MSAT, individuals do not need to
seek treatment for clinical infections since their infections
would be detected and treated during MSAT at a suitably
high coverage (80%). This is also a conservative assump-
tion.
Since the models are deterministic, the prevalence of
malaria will not reduce to a value of exactly zero. Elimina-
tion is therefore defined as having been achieved when
the parasite prevalence has reduced to less than 0.001%
and the rate of change of parasite prevalence thereafter is
negative. Other modelling work has demonstrated that
definitions of this type in deterministic models are con-
sistent with their stochastic counterparts (see [5] for exam-
ple). A different threshold will alter the predicted time to
elimination by a few years but not the qualitative behav-
iour of the model.
A user-friendly web-based version of the elimination
model is currently under development [16].
Results and Discussion
As Figure 1 illustrates, in the absence of drug resistance,
for low transmission intensities (up to about 20% parasite
prevalence) it is predicted that presumptive treatment of
clinical cases with a sufficiently high coverage (60%) is
adequate for elimination. For intermediate transmission
intensities (from 20% to 50% parasite prevalence), the
model predicts that the introduction of any one of MSAT,
ITN or annual vaccination, at the levels described earlier,
would be adequate to eliminate malaria infection. ForMalaria Journal 2009, 8:212 http://www.malariajournal.com/content/8/1/212
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Top: Diagram illustrating the % parasite prevalence thresholds under which elimination is predicted for single and combinations  of interventions Figure 1
Top: Diagram illustrating the % parasite prevalence thresholds under which elimination is predicted for single 
and combinations of interventions. The large scale represents settings where drug resistance is not spreading and the 
small scale below represents settings where drug resistance is already spreading. Bottom: A graph showing the percentage par-
asite prevalence over time for all combinations of up to three currently available control measures (increased vector control; 
mass screen and treat; annual mass vaccination) compared with treatment of clinical infection only (solid black line). Single 
measures (solid red) are compared with two combined measures (dashed blue) and three combined measures (solid green).
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intermediate to high transmission intensities (from 50%
to 75% parasite prevalence), any two combined interven-
tions at least would be required for elimination of malaria
infection. For very high levels of transmission (parasite
prevalence from 75% to 85%) three combined interven-
tions are predicted to be required to eliminate malaria
infection. Resistance spreading at a given speed is pre-
dicted to have the effect of decreasing the prevalence
thresholds for elimination for each strategy, rendering
some strategies ineffective in any setting.
For a high transmission setting (75% parasite prevalence
with 10% of infections being clinically apparent, Figure 1)
into which a single intervention (red solid), pairs of inter-
ventions (blue dashed), or a combination of all three
(green solid) are introduced, only a combination of all
three interventions was sufficient to reduce the predicted
reproduction number below unity, thus predicting that
elimination would be possible.
Impact of elimination strategies
Unless otherwise stated, conditions are varied using a
starting point of the three-intervention combined elimi-
nation strategy (green line in Figure 1).
If the pre-intervention parasite prevalence is varied from
20% to 98% (Figure 2A and 2E), then the predicted
impact on clinical infection of strategies not including
MSAT is positive for all transmission settings. When MSAT
is included, the predicted impact can be negative. This
negative impact arises from resistance spread being accel-
erated by MSAT to the point where the elimination strat-
egy fails. In lower transmission settings, during successful
elimination campaigns, the selective pressure is predicted
to be positive, even for strategies including MSAT, mean-
ing that there is less selective pressure from the campaign
compared to standard presumptive treatment. For higher
transmission settings, the impact on selective pressure is
negative and is significantly lower when elimination fails.
Increasing vector control efficacy levels and vaccination
coverage levels have similar effects (Figure 2B, F, C and
2G). Unsuccessful elimination strategies are predicted to
have a negative impact on clinical infections (again only
if drug resistance is spreading) (Figure 2B and 2D). For
levels above those required for elimination, both vector
control efficacy and annual vaccination coverage have
threshold levels above which the impact on selective pres-
sure is positive (Figure 2F and 2G), predicting that the use
of these interventions at high enough coverage in combi-
nation with MSAT will act to prevent or even reverse the
spread of resistance during the campaign.
Cessation of a strategy before elimination is achieved pre-
dicts a cumulative decrease in clinical infection in the
absence of the spread of resistance. If resistance is spread-
Graphs showing the percentage impact of specific strategies on cumulative clinical cases (top row) and cumulative drug pres- sure (bottom row) Figure 2
Graphs showing the percentage impact of specific strategies on cumulative clinical cases (top row) and cumu-
lative drug pressure (bottom row). In graphs A and E, the pre-intervention parasite prevalence was varied for all the strat-
egies used to produce Figure 1, the colour scheme being the same. In the remaining graphs (B-D and F-H) four transmission 
settings were considered given pre-intervention parasite prevalences of: 65% (light blue); 70% (dark red); 75% (light green); 
80% (purple). In graphs B and F the percentage effect on the force of infection of vector control was varied and modelled in 
combination with mass-vaccination and MSAT at the levels used to produce the green line in Figure 1. In graphs C and G, the 
level of coverage of annual vaccination was varied for a vaccine with duration of 1 (solid lines) and 10 (dashed lines) years and 
modelled in combination with vector control and MSAT at the levels used to produce the green line in Figure 1. In graphs D 
and H, the number of years since the beginning of the elimination strategy (see figure 1) until a reversion to the original control 
strategy is varied.
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ing, then the early cessation of the strategy is predicted to
result in more clinical infection due to the acceleration of
resistance spread by the MSAT component of the strategy
(Figure 2D and 2H).
If a single dose of a transmission blocking drug is assumed
as resulting in a 90% reduction in infectiousness lasting
two weeks, then results indicate that an annual MSAT
would not be effective whereas continuous administra-
tion, in combination with all treated cases for the dura-
tion of infection, has a similar effect as an annual mass-
vaccination strategy. The action of a transmission-block-
ing drug is assumed to be orthogonal to the other three
approaches. That is, that the transmission blocking effects
are assumed independent of the effects of the other con-
trols with no redundancy.
Comparison with other models
In this section, the simple model developed here is com-
pared with specific examples from three more complex
models using similar input parameters to demonstrate the
ability of the simple elimination model to reproduce the
qualitative behaviour of more complex models.
An individual-based model with MSAT and vector control
This is a stochastic individual-based model [17] that com-
bines MSAT reaching 80% in three months in February
and ITNs started in June with 30% reduction in transmis-
sion and seasonal transmission (amplitude of transmis-
sion 50%). The model is presented in the original
publication for three different transmission settings (with
pre-intervention parasite prevalences of about 40%, 70%
and 80%). The simple model can replicate the general
behaviour with the same input parameters for all three
transmission settings (Figure 3). Seasonality has the effect
of enhancing the post-intervention nadir of parasite prev-
alence in high transmission settings.
An individual-based model to predict the impact of vaccination
This is an individual based model [18] that assumes a cov-
erage of 89% with a protective effect against infection with
initial values of 30%, 55%, 80% and 100% that decrease
in value with a half life of 10 years. The simple model
assumes fixed (i.e. not waning) effects of 30%, 55%, 80%
and 100% with an average duration to give a half-life of
10 years with a pre-intervention parasite prevalence of
58% and coverage of 89%. The pre-intervention preva-
lence of 58% was chosen as suitable to reflect the preva-
lence distribution with age, shown in Figure 2A of [18].
The simpler model does not capture the subtle transient
dynamics (such as the plateau in time) or within-host
dynamics, but does predict similar values and behaviour
in the short term (Figure 4).
A multi-strain model to consider elimination in the presence of 
significant drug resistance
Deterministic and stochastic time-series models that
explicitly model the dynamics of drug usage and decay
with transmission of sensitive and resistant strains of the
parasite [5]. Both models show that an elimination strat-
egy using anti-malarial drugs will precipitate a more rapid
spread of resistance than typical control (Figure 5). Both
models also warn against the early cessation of such a
strategy (see Figure 2, graph D).
Conclusion
With the proliferation of partially effective interventions
proposed for the elimination of malaria, informed
choices are needed now on how they should be used. Sim-
ple compartmental modelling allows the effects of large
number of possible combinations of controls and admin-
istration methods to be predicted across a range of trans-
mission settings. The model presented here is deliberately
simple in nature. It is for the purposes of understanding
the more general behaviour of malaria transmission spe-
cifically during elimination and could be used as a first
step by policy makers for strategy planning for a few years
ahead. The benefit of a simple model is that it requires
very little data input and can be run quickly for a range of
scenarios. For longer term planning, more complex mod-
els are required. The benefit of such models is that they are
likely to predict accurately for a longer time period, but
only if they are correctly parameterized with large and
multiple datasets for the specific country. If these data are
not available an alternative approach is to use simple
models initially and then upgrade them with increasing
complexity as more data are collected during the elimina-
tion process. This approach has been applied successfully
for other diseases in the UK by the Health Protection
Agency [19].
A simple mathematical model is used here to demonstrate
the interrelationships between different interventions and
the potential for elimination when they are combined.
The qualitative behaviour corresponds well to that of
three more complex models that consider different
aspects of malaria transmission in far more detail. Com-
prehensive models that consider every aspect of malaria
transmission and infection are highly computer intensive,
often sensitive to poorly characterized input parameters,
and the time required to run all combinations of potential
interventions could be longer than the time available to
contribute to elimination policies within a realistic time-
frame. The number of combinations of interventions is
large. Simple models that can consider many scenarios in
a short length of time are useful in reducing the number
of runs required for the more complex but computer
intensive models tailored to specific regions. The ability of
this simple model to reproduce the main trends predictedMalaria Journal 2009, 8:212 http://www.malariajournal.com/content/8/1/212
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by its more complex counterparts is demonstrated indicat-
ing its value as a precursor to more complex models to
allow predominant trends and behaviours to be explored
very quickly before quantitative predictions and recom-
mendations are retrieved.
The model includes one interaction between interven-
tions as an example, namely that when MSAT is active we
assume that presumptive treatment does not occur. Other
interactions that may negatively affect elimination (such
as the possibility that individuals who experience high
biting rates also experience a lower coverage from vaccina-
tion) have not been considered. By definition, a simple
model does not include everything. However the simple
model structure could easily be extended to include such
an effect if it were considered significant for a particular
setting. For this example, individuals not covered by vac-
cination could be given a higher transmission coefficient
during the intervention.
Graphs comparing predictions from a complex model (graphs A to C copied from graphs A to C, Figure Three in [17]) and the  simple elimination model with (solid) and without (dashed) seasonal forcing (graphs D to F) for the effect on parasite preva- lence of a double intervention of MSAT and increased bed net usage for a range of transmission intensities Figure 3
Graphs comparing predictions from a complex model (graphs A to C copied from graphs A to C, Figure Three 
in [17]) and the simple elimination model with (solid) and without (dashed) seasonal forcing (graphs D to F) for 
the effect on parasite prevalence of a double intervention of MSAT and increased bed net usage for a range of 
transmission intensities.
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If resistance is not spreading, predictions for impact on
clinical infection are positive even when elimination fails.
This is because, in the absence of an elimination strategy,
transmission and clinical infection will continue at the
same level, resulting in an accumulation of cases of clini-
cal infection. An elimination strategy is likely to involve
aggressive treatment of infected individuals regardless of
their clinical signs. Early cessation of an aggressive elimi-
nation strategy in a high transmission setting and the
resulting rebound in clinical infection (due to increased
transmission in a population with reduced immunity)
was considered. This is predicted to have a deleterious
effect only in the presence of the spread of resistance. Even
some successful elimination strategies will result in higher
selective pressure than control. However, in combination
with other interventions, such as vector control or vacci-
nation, the deleterious effects can be abated and in some
cases removed completely. This analysis provides evi-
dence for the argument that attempting malaria elimina-
tion using a suitable strategy is low risk in terms of the
burden of clinical disease and the spread of drug resist-
ance.
The model presented here can also be used for the initial
stages of target product profiling in terms of the target effi-
cacy levels and durations required for a given product
Graphs comparing predictions from a complex model (graph A copied from graph a, Figure Four in [18]; graph C copied from  graph a, Figure Six in [18]; graph E copied from graph a, Figure Seven in [18]) and the simple elimination model (graphs B, D  and F) for the effect of vaccination at birth on cumulative incidence of all malaria infections at various efficacies, with various  vaccine half-lives and at various coverage levels respectively Figure 4
Graphs comparing predictions from a complex model (graph A copied from graph a, Figure Four in [18]; graph 
C copied from graph a, Figure Six in [18]; graph E copied from graph a, Figure Seven in [18]) and the simple 
elimination model (graphs B, D and F) for the effect of vaccination at birth on cumulative incidence of all 
malaria infections at various efficacies, with various vaccine half-lives and at various coverage levels respec-
tively.Malaria Journal 2009, 8:212 http://www.malariajournal.com/content/8/1/212
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applied in combination with of a range of interventions
for a range of transmission settings. The model can be
used to propose suitable delivery strategies of new and
existing products and to assess the most likely relative effi-
cacy of such products.
In conclusion, the modelling exercise demonstrates that
combining interventions with suitable delivery strategies
can protect drugs from selective pressure through indirect
effects on the transmission dynamics. Also, single inter-
ventions that have previously been assessed as weak can
be combined to make a seemingly unhopeful strategy
more likely to succeed due to the herd effect of combining
strategies. This is a conclusion that reiterates the results of
previous modelling work [20-22]. Furthermore, in the
current climate of increased commitment to the eradica-
tion of malaria, the model results indicate that even in a
high transmission setting a suitable combination of inter-
ventions could achieve elimination through a sustained
aggressive integrated control strategy without significantly
increasing selective pressure against anti-malarial drugs.
Abbreviations
ITN: insecticide-treated bed net; WHO: World Health
Organization; MAST: mass screen and treat; ACT: artemisi-
nin combination therapy.
Competing interests
TE is an employee of GlaxoSmithKline Biologicals.
Authors' contributions
LW developed the model structures (based on previous
work by RA, LW et al.) and performed the mathematical
analysis. RM, WP, SS, TE, and RA participated in develop-
ing the initial concept of the study, review of the mathe-
matical analysis and manuscript revision. RM, ND and
NW provided the clinical context of the study and partici-
pated in manuscript revision. All authors read and
approved the final manuscript.
Additional material
Acknowledgements
Mahidol-Oxford Tropical medicine Research Unit is funded by the Well-
come Trust of Great Britain. The authors thank anonymous Reviewer 1 for 
insightful comments and suggestions for revision.
References
1. Rieckmann KH: The chequered history of malaria control: are
new and better tools the ultimate answer?  Ann Trop Med Para-
sitol 2006, 100:647-62.
2. Cross AP, Singer B: Modelling the development of resistance of
Plasmodium falciparum to anti-malarial drugs.  Trans R Soc
Trop Med Hyg 1991, 85:349-55.
3. Mackinnon MJ: Drug resistance models for malaria.  Acta Tropica
2005, 94:207-17.
4. Greenwood B: Can malaria be eliminated?  Trans R Soc Trop Med
Hyg 2009, 103:S2-5.
5. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Don-
dorp AM, Day NP, White NJ, White LJ: The last man standing is
the most resistant: eliminating artemisinin-resistant malaria
in Cambodia.  Malar J 2009, 8:31.
Additional file 1
Mathematical models.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2875-8-212-S1.pdf]
Graphs comparing predictions from a complex model (graph A copied from Figure Three in [5]) and the simple elimination  model (graph B) for the dynamics of sensitive and resistant parasite prevalence during an annual MSAT elimination strategy  over 20 years Figure 5
Graphs comparing predictions from a complex model (graph A copied from Figure Three in [5]) and the sim-
ple elimination model (graph B) for the dynamics of sensitive and resistant parasite prevalence during an 
annual MSAT elimination strategy over 20 years.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2009, 8:212 http://www.malariajournal.com/content/8/1/212
Page 10 of 10
(page number not for citation purposes)
6. Hommel M: Towards a research agenda for global malaria
elimination.  Malar J 2008, 7(Suppl 1):S1.
7. Maude RJ, Pontavornpinyo W, Saralamba S, Dondorp AM, Day NP,
White NJ, White LJ: The role of mathematical modelling in
malaria elimination and eradication (Comment on: Can
malaria be eliminated?).  Trans R Soc Trop Med Hyg 2009,
103:643-4.
8. Molyneux DH, Hopkins DR, Zagaria N: Disease eradication, elim-
ination and control: the need for accurate and consistent
usage.  Trends Parasitol 2004, 20:347-51.
9. Smith DL, Hay SI: Endemicity response timelines for Plasmo-
dium falciparum elimination.  Malar Journal 2009, 8:87.
10. Boni MF, Smith DL, Laxminarayan R: Benefits of using multiple
first-line therapies against malaria.  Proc Natl Acad Sci U S A 2008,
105:14216-21.
11. Aguas R, White LJ, Snow RW, Gomes MG: Prospects for malaria
eradication in sub-Saharan Africa.  PLoS ONE 2008, 3:e1767.
12. Sochantha T, Hewitt S, Nguon C, Okell L, Alexander N, Yeung S, Van-
nara H, Rowland M, Socheat D: Insecticide-treated bednets for
the prevention of Plasmodium falciparum malaria in Cam-
bodia: a cluster-randomized trial.  Trop Med Int Health 2006,
11:1166-77.
13. Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Mshamu
S, Lang T, Gould J, Dubois MC, Demoitie MA, Stallaert JF, Vansadia P,
Carter T, Njuguna P, Awuondo KO, Malabeja A, Abdul O, Gesase S,
Mturi N, Drakeley CJ, Savarese B, Villafana T, Ballou WR, Cohen J,
Riley EM, Lemnge MM, Marsh K, von Seidleinl L: Efficacy of RTS, S/
AS01E vaccine against malaria in children 5 to 17 months of
age.  N Engl J Med 2008, 359:2521-32.
14. Maire N, Aponte JJ, Ross A, Thompson R, Alonso P, Utzinger J, Tan-
ner M, Smith T: Modeling a field trial of the RTS, S/AS02A
malaria vaccine.  Am J Trop Med Hyg 2006, 75:104-10.
15. Crockett M, Kain KC: Tafenoquine: a promising new antimalar-
ial agent.  Expert Opin Investig Drugs 2007, 16:705-15.
16. Malaria Elimination Model   [http://www.tropmedres.ac/elimina
tion]
17. Gu W, Killeen GF, Mbogo CM, Regens JL, Githure JI, Beier JC: An
individual-based model of Plasmodium falciparum malaria
transmission on the coast of Kenya.  Trans R Soc Trop Med Hyg
2003, 97:43-50.
18. Maire N, Tediosi F, Ross A, Smith T: Predictions of the epidemi-
ologic impact of introducing a pre-erythrocytic vaccine into
the expanded program on immunization in sub-Saharan
Africa.  Am J Trop Med Hyg 2006, 75:111-8.
19. Osborne K, Gay N, Hesketh L, Morgan-Capner P, Miller E: Ten
years of serological surveillance in England and Wales: meth-
ods, results, implications and action.  Int J Epidemiol 2000,
29:362-8.
20. Ross R: The prevention of malaria.  London: Murray, J; 1911. 
21. McKenzie FE, Baird JK, Beier JC, Lal AA, Bossert WH: A biologic
basis for integrated malaria control.  Am J Trop Med Hyg 2002,
67:517-7.
22. Killeen GF, McKenzie FE, Foy BD, Schieffelin C, Billingsley PF, Beier
JC: The potential impact of integrated malaria transmission
control on entomologic inoculation rate in highly endemic
areas.  Am J Trop Med Hyg 2000, 62:545-51.